Jacqueline Shea
Chief Executive Officer chez INOVIO PHARMACEUTICALS, INC.
Fortune : 284 707 $ au 31/03/2024
Postes actifs de Jacqueline Shea
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 16/05/2022 | - |
| Chief Executive Officer | 10/05/2022 | - | |
| President | 10/05/2022 | - | |
| Chief Operating Officer | 25/03/2019 | 10/05/2022 | |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Director/Board Member | 13/08/2019 | - |
Historique de carrière de Jacqueline Shea
Anciens postes connus de Jacqueline Shea
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Director/Board Member | 01/04/2014 | 01/08/2015 |
| Chief Executive Officer | 01/08/2015 | 01/12/2018 | |
| Chief Operating Officer | 01/04/2014 | 01/08/2015 | |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/05/2013 | 01/03/2014 |
| The Oxford-Emergent Tuberculosis Consortium Ltd. | Corporate Officer/Principal | 01/01/2008 | 01/01/2013 |
Formation de Jacqueline Shea
| University of Bath | Undergraduate Degree |
| The National Institute For Medical Research | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 4 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Chief Operating Officer | 2 |
Sectorielle
| Commercial Services | 3 |
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
| The Oxford-Emergent Tuberculosis Consortium Ltd. |
- Bourse
- Insiders
- Jacqueline Shea
- Expérience
